Skip to main content
Premium Trial:

Request an Annual Quote

Medical Solutions to Distribute Empire Genomics' Genotyping Technology

NEW YORK (GenomeWeb News) – Medical Solutions will be the exclusive UK distributor and service provider for Empire Genomics’ AccuArray array comparative genomic hybridization genotyping technology under an alliance announced today.
 
In addition to distributing the technology, Nottingham, UK-based Medical Solutions said that it would offer genotyping services, including in-house bioinformatics analysis and support, using the technology in its labs. The AccuArray also has applications in clinical diagnostics and pharmacogenetic testing, the firms said.
 
“The diagnostic capability of this assay is of particular interest to those groups in the healthcare community involved in cytogenetic and pre- and post-natal testing,” Tom Weaver, commercial director for Medical Solutions, said in a statement.
 
He said the AccuArray aCGH could be used to identify genetic aberrations linked with several diseases and conditions, such as cancer, autism, Alzheimer’s, several congenital abnormalities, and Down Syndrome.
 
Terms of the alliance were not disclosed.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.